ArticleEnvironmental health perspectives2022
Examining the Relationship between Climate Change and Vibriosis in the United States: Projected Health and Economic Impacts for the 21st Century.
Article in Environmental health perspectives, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Impact of environmental factors and climate conditions on the occurrence of Vibrio and Shewanella infections in Norway, 2014-2018.BMC public health · 2026Article
- Quantifying Vibrio Infection Risks From Beach Recreation Along U.S. Eastern Seaboard in Year 2100.GeoHealth · 2026Article
- Increased pathogens and reduced intestinal immune genes associated with fish diseases during the winter-spring transition.International microbiology : the official journal of the Spanish Society for Microbiology · 2025Article
- Distribution, Antibiotic Resistance, and Virulence Factors ofAntibiotics (Basel, Switzerland) · 2025Article
- Homologous relationship between FabG involved in fatty acid biosynthesis and SDR on chromosome II in the multi-chromosome pathogen Vibrio anguillarum.Scientific reports · 2025Article
- Epidemiological and genetic charateristics of Vibrio vulnificus from diverse sources in China during 2012-2023.Communications biology · 2025Article
- Planning and managing for resilient natural resources and communities in the USA: the EPA Organon.Socio-ecological practice research · 2025Review
- Quantifying national burdens of foodborne disease-Four imperatives for global impact.PLOS global public health · 2025Review
- Quantification of Climate Footprints ofGeoHealth · 2024Article
- Increased incidence of vibriosis in Maryland, U.S.A., 2006-2019.Environmental research · 2024Article
- Rapid visual nucleic acid detection of Vibrio alginolyticus by recombinase polymerase amplification combined with CRISPR/Cas13a.World journal of microbiology & biotechnology · 2023Article
- Invited Perspective: Vibriosis-The Price Tag of a Warmer World.Environmental health perspectives · 2022Article
Corrections and comments
- Commented on by
- Erratum issued
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis paper represents, to our knowledge, the first national-level (United States) estimate of the economic impacts of vibriosis cases as exacerbated by climate change. Vibriosis is an illness contracted through food- and waterborne exposures to various
objectivesThe objective of this study was to project climate-induced changes in vibriosis and associated economic impacts in the United States related to changes in sea surface temperatures (SSTs).
methodsFor our analysis to identify climate links to vibriosis incidence, we constructed three logistic regression models by
resultsBy 2090, increases in SST are estimated to result in a 51% increase in cases annually relative to the baseline era (centered on 1995) under Representative Concentration Pathway (RCP) 4.5, and a 108% increase under RCP8.5. The cost of these illnesses is projected to reach DISCUSSION: Vibriosis incidence is likely to increase in the United States under moderate and unmitigated climate change scenarios through increases in SST, resulting in a substantial burden of morbidity and mortality, and costing billions of dollars. These costs are mostly attributable to deaths, primarily from exposure to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.